Company / Operating Cash Flow
PROKIDNEY CORP. Operating Cash Flow History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Cash Flow
-$126.4M
FY2024
5-year range
-$126.4M / -$25.2M
FY2020-FY2024
Trend
-40.3%
vs FY2023
Sector context
#136 of 216
Health Care
What the data says
At -$126M, PROKIDNEY CORP.'s operating cash flow ranks #136 of 216 in the Health Care sector. Operating Cash Flow has declined for 4 consecutive years, from -$25M in FY2020 to -$126M in FY2024.
Based on SEC 10-K filings.
-$126M in FY2024.
Declined from -$77M to -$126M over the past 2 years.
Health Care sector context is included.
Operating Cash Flow over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#136 of 216 in Health CareTop 63% of 216This company -$126.4M Sector average $658.7M
▼
-119.2% below sector average
Key checks
Key Insights
- PROKIDNEY CORP.'s operating cash flow has declined for 4 consecutive years.
- In FY2024, operating cash flow decreased 40.3% year-over-year.
- Ranks #136 out of 216 companies in the Health Care sector.
- Peak operating cash flow was recorded in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 0/9 (multiple financial health concerns)
- Altman Z-Score -1.00 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Cash FlowValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$126.4M | -40.3% |
| FY2023 | -$90.1M | -16.8% |
| FY2022 | -$77.1M | -53.3% |
| FY2021 | -$50.3M | -99.7% |
| FY2020 | -$25.2M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026